17q21 locus and ORMDL3: An increased risk for childhood asthma

Pediatric Research

Volumn 75, Issue 1-2, 2014, Pages 165-170

  Ono, Jennie G ^a   Worgall, Tilla S ^b,c   Worgall, Stefan ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; CALCIUM; CERAMIDE; CXCL11 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SPHINGOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; STAT6 PROTEIN;

AIRWAY REMODELING; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; CALCIUM CELL LEVEL; CELL ACTIVATION; CHILD; CHILDHOOD DISEASE; CHROMOSOME 17Q; DNA METHYLATION; ENDOPLASMIC RETICULUM STRESS; ENVIRONMENTAL EXPOSURE; EPITHELIUM CELL; GASDERMIN B GENE; GENE; GENE LOCUS; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOMEOSTASIS; HUMAN; IKAROS ZINC FINGER PROTEIN 3 GENE; LIPOGENESIS; MEDIATOR OF RNA POLYMERASE II TRANSCRIPTION SUBUNIT 24 GENE; OROSOMUCOID LIKE 3 GENE; PRIORITY JOURNAL; PROTEIN QUALITY; RESPIRATORY TRACT ALLERGY; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; UNFOLDED PROTEIN RESPONSE; CALCIUM HOMEOSTASIS; CHILDHOOD; ENVIRONMENTAL FACTOR; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION;

AGE FACTORS; AIRWAY REMODELING; ANTI-ASTHMATIC AGENTS; ASTHMA; CHROMOSOMES, HUMAN, PAIR 17; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LUNG; MEMBRANE PROTEINS; PHENOTYPE; PROGNOSIS; RISK FACTORS;

EID: 84900456770     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.186     Document Type: Review

References (75)

1. Ober C, Yao TC. The genetics of asthma and allergic disease: a 21st century perspective. Immunol Rev 2011;242:10-30.
2. Gary PA. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008;372:1107-19.
3. Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol 2011;127:145-52.
4. McGrath KW, Icitovic N, Boushey HA, et al.; Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 2012;185:612-9.
5. Paul MOB. Therapeutic strategies to reduce asthma exacerbations. J Allergy Clin Immunol 2011;128:257-63.
6. Moffatt MF, Kabesch M, Liang L, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007;448:470-3.
7. Flory JH, Sleiman PM, Christie JD, et al. 17q12-21 variants interact with smoke exposure as a risk factor for pediatric asthma but are equally associated with early-onset versus late-onset asthma in North Americans of European ancestry. J Allergy Clin Immunol 2009;124:605-7.
8. Caliskan M, Bochkov YA, Kreiner-Moller E, et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med 2013;368:1398-407.
9. Granell R, Henderson AJ, Timpson N, et al. Examination of the relationship between variation at 17q21 and childhood wheeze phenotypes. J Allergy Clin Immunol 2013;131:685-94.
10. Verlaan DJ, Berlivet S, Hunninghake GM, et al. Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease. Am J Hum Genet 2009;85:377-93.
11. Moffatt MF, Gut IG, Demenais F, et al.; GABRIEL Consortium. A largescale, consortium-based genomewide association study of asthma. N Engl J Med 2010;363:1211-21.
12. Galanter J, Choudhry S, Eng C, et al. ORMDL3 gene is associated with asthma in three ethnically diverse populations. Am J Respir Crit Care Med 2008;177:1194-200.
13. Hirota T, Harada M, Sakashita M, et al. Genetic polymorphism regulating ORM1-like 3 (Saccharomyces cerevisiae) expression is associated with childhood atopic asthma in a Japanese population. J Allergy Clin Immunol 2008;121:769-70.
14. Leung TF, Sy HY, Ng MC, et al. Asthma and atopy are associated with chromosome 17q21 markers in Chinese children. Allergy 2009;64:621-8.
15. Yang FF, Huang Y, Li QB, Dai JH, Fu Z. Single nucleotide polymorphisms in the ORM1-like 3 gene associated with childhood asthma in a Chinese population. Genet Mol Res 2012;11:4646-53.
16. Tavendale R, Macgregor DF, Mukhopadhyay S, Palmer CN. A polymorphism controlling ORMDL3 expression is associated with asthma that is poorly controlled by current medications. J Allergy Clin Immunol 2008;121:860-3.
17. Sleiman PM, Annaiah K, Imielinski M, et al. ORMDL3 variants associated with asthma susceptibility in North Americans of European ancestry. J Allergy Clin Immunol 2008;122:1225-7.
18. Bouzigon E, Corda E, Aschard H, et al. Effect of 17q21 variants and smoking exposure in early-onset asthma. N Engl J Med 2008;359:1985-94.
19. Madore AM, Tremblay K, Hudson TJ, Laprise C. Replication of an association between 17q21 SNPs and asthma in a French-Canadian familial collection. Hum Genet 2008;123:93-5.
20. Torgerson DG, Ampleford EJ, Chiu GY, et al.; Mexico City Childhood Asthma Study (MCAAS); Children's Health Study (CHS) and HARBORS study; Genetics of Asthma in Latino Americans (GALA) Study, Study of Genes-Environment and Admixture in Latino Americans (GALA2) and Study of African Americans, Asthma, Genes & Environments (SAGE); Childhood Asthma Research and Education (CARE) Network; Childhood Asthma Management Program (CAMP); Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE); Genetic Research on Asthma in African Diaspora (GRAAD) Study. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 2011;43:887-92.
21. Johansson SG, Lundahl J. Asthma, atopy, and IgE: what is the link? Curr Allergy Asthma Rep 2001;1:89-90.
22. Binia A, Khorasani N, Bhavsar PK, et al. Chromosome 17q21 SNP and severe asthma. J Hum Genet 2011;56:97-8.
23. Bisgaard H, Bonnelykke K, Sleiman PM, et al. Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood. Am J Respir Crit Care Med 2009;179:179-85.
24. Han S, Lone MA, Schneiter R, Chang A. Orm1 and Orm2 are conserved endoplasmic reticulum membrane proteins regulating lipid homeostasis and protein quality control. Proc Natl Acad Sci USA 2010;107:5851-6.
25. Mahn K, Hirst SJ, Ying S, et al. Diminished sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma. Proc Natl Acad Sci USA 2009;106:10775-80.
26. Miller M, Tam AB, Cho JY, et al. ORMDL3 is an inducible lung epithelial gene regulating metalloproteases, chemokines, OAS, and ATF6. Proc Natl Acad Sci USA 2012;109:16648-53.
27. Worgall TS, Veerappan A, Sung B, et al. Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity Sci Transl Med 2013;186:186ra67.
28. Hjelmqvist L, Tuson M, Marfany G, Herrero E, Balcells S, Gonzalez-Duarte R. ORMDL proteins are a conserved new family of endoplasmic reticulum membrane proteins. Genome Biol 2002;3:RESEARCH0027.
29. Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011;334:1081-6.
30. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010;140:900-17.
31. Adachi Y, Yamamoto K, Okada T, Yoshida H, Harada A, Mori K. ATF6 is a transcription factor specializing in the regulation of quality control proteins in the endoplasmic reticulum. Cell Struct Funct 2008;33:75-89.
32. Hovnanian A. SERCA pumps and human diseases. Subcell Biochem 2007;45:337-63.
33. Parameswaran K, Janssen LJ, O'Byrne PM. Airway hyperresponsiveness and calcium handling by smooth muscle: a "deeper look". Chest 2002;121:621-4.
34. Cantero-Recasens G, Fandos C, Rubio-Moscardo F, Valverde MA, Vicente R. The asthma-associated ORMDL3 gene product regulates endoplasmic reticulum-mediated calcium signaling and cellular stress. Hum Mol Genet 2010;19:111-21.
35. Hsu KJ, Turvey SE. Functional analysis of the impact of ORMDL3 expression on inflammation and activation of the unfolded protein response in human airway epithelial cells. Allergy Asthma Clin Immunol 2013;9:4.
36. Carreras-Sureda A, Cantero-Recasens G, Rubio-Moscardo F, et al. ORMDL3 modulates store-operated calcium entry and lymphocyte activation. Hum Mol Genet 2013;22:519-30.
37. Breslow DK, Weissman JS. Membranes in balance: mechanisms of sphingolipid homeostasis. Mol Cell 2010;40:267-79.
38. Breslow DK, Collins SR, Bodenmiller B, et al. Orm family proteins mediate sphingolipid homeostasis. Nature 2010;463:1048-53.
39. Roelants FM, Breslow DK, Muir A, Weissman JS, Thorner J. Protein kinase Ypk1 phosphorylates regulatory proteins Orm1 and Orm2 to control sphingolipid homeostasis in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 2011;108:19222-7.
40. Siow DL, Wattenberg BW. Mammalian ORMDL proteins mediate the feedback response in ceramide biosynthesis. J Biol Chem 2012;287:40198-204.
41. Halapi E, Gudbjartsson DF, Jonsdottir GM, et al. A sequence variant on 17q21 is associated with age at onset and severity of asthma. Eur J Hum Genet 2010;18:902-8.
42. Hanada K. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim Biophys Acta 2003;1632:16-30.
43. Merrill AH Jr. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem 2002;277:25843-6.
44. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008;9:139-50.
45. Dennis E, Vance JEV, eds
46. Merrill AH Jr, Sandhoff K. Sphingolipids: metabolism and cell signaling. In: Dennis E, Vance JEV, eds. New Comprehensive Biochemistry, vol.36 Elsevier, 2002:373-407.
47. Walther TC. Keeping sphingolipid levels nORMal. Proc Natl Acad Sci USA 2010;107:5701-2.
48. Sun Y, Miao Y, Yamane Y, et al. Orm protein phosphoregulation mediates transient sphingolipid biosynthesis response to heat stress via the Pkh-Ypk and Cdc55-PP2A pathways. Mol Biol Cell 2012;23:2388-98.
49. Ammit AJ, Hastie AT, Edsall LC, et al. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J 2001; 15:1212-4.
50. Fyrst H, Saba JD. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol 2010;6:489-97.
51. Jolly PS, Rosenfeldt HM, Milstien S, Spiegel S. The roles of sphingosine-1-phosphate in asthma. Mol Immunol 2002;38:1239-45.
52. Lai WQ, Goh HH, Bao Z, Wong WS, Melendez AJ, Leung BP. The role of sphingosine kinase in a murine model of allergic asthma. J Immunol 2008;180:4323-9.
53. Rosenfeldt HM, Amrani Y, Watterson KR, Murthy KS, Panettieri RA Jr, Spiegel S. Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells. FASEB J 2003;17:1789-99.
54. Roviezzo F, D'Agostino B, Brancaleone V, et al. Systemic administration of sphingosine-1-phosphate increases bronchial hyperresponsiveness in the mouse. Am J Respir Cell Mol Biol 2010;42:572-7.
55. Kume H, Takeda N, Oguma T, et al. Sphingosine 1-phosphate causes airway hyper-reactivity by rho-mediated myosin phosphatase inactivation. J Pharmacol Exp Ther 2007;320:766-73.
56. Roviezzo F, Di Lorenzo A, Bucci M, et al. Sphingosine-1-phosphate/ sphingosine kinase pathway is involved in mouse airway hyperresponsiveness. Am J Respir Cell Mol Biol 2007;36:757-62.
57. Ryan JJ, Spiegel S. The role of sphingosine-1-phosphate and its receptors in asthma. Drug News Perspect 2008;21:89-96.
58. Ble FX, Cannet C, Zurbruegg S, et al. Activation of the lung S1P(1) receptor reduces allergen-induced plasma leakage in mice. Br J Pharmacol 2009;158:1295-301.
59. Lai WQ, Wong WS, Leung BP. Sphingosine kinase and sphingosine 1-phosphate in asthma. Biosci Rep 2011;31:145-50.
60. Nishiuma T, Nishimura Y, Okada T, et al. Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. Am J Physiol Lung Cell Mol Physiol 2008;294:L1085-93.
61. Tagaya E, Tamaoki J. Mechanisms of airway remodeling in asthma. Allergol Int 2007;56:331-40.
62. Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med 2012;18:684-92.
63. Malmstrom K, Pelkonen AS, Makela MJ. Remodeling, inflammation and airway responsiveness in early childhood asthma. Curr Opin Allergy Clin Immunol 2013;13:203-10.
64. Tourdot S, Mathie S, Hussell T, et al. Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization. Clin Exp Allergy 2008;38:1016-24.
65. Keularts IM, Leroy PL, Rubio-Gozalbo EM, et al. Fatal cerebral edema associated with serine deficiency in CSF. J Inherit Metab Dis 2010;33:Suppl 3:S181-5.
66. Nikolova-Karakashian MN, Reid MB. Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle. Antioxid Redox Signal 2011;15:2501-17.
67. Sabbadini RA, Betto R, Teresi A, Fachechi-Cassano G, Salviati G. The effects of sphingosine on sarcoplasmic reticulum membrane calcium release. J Biol Chem 1992;267:15475-84.
68. Jacobs LS, Kester M. Sphingolipids as mediators of effects of plateletderived growth factor in vascular smooth muscle cells. Am J Physiol 1993;265(3 Pt 1):C740-7.
69. Dominguez LJ, Barbagallo M, Di Lorenzo G, et al. Bronchial reactivity and intracellular magnesium: a possible mechanism for the bronchodilating effects of magnesium in asthma. Clin Sci 1998;95:137-42.
70. Hashimoto Y, Nishimura Y, Maeda H, Yokoyama M. Assessment of magnesium status in patients with bronchial asthma. J Asthma 2000;37:489-96.
71. Kowal A, Panaszek B, Barg W, Obojski A. The use of magnesium in bronchial asthma: a new approach to an old problem. Arch Immunol Ther Exp (Warsz) 2007;55:35-9.
72. Smit LA, Bouzigon E, Pin I, et al.; EGEA Cooperative Group. 17q21 variants modify the association between early respiratory infections and asthma. Eur Respir J 2010;36:57-64.
73. Ege MJ, Mayer M, Normand AC, et al.; GABRIELA Transregio 22 Study Group. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 2011;364:701-9.
74. Barnes PJ. New drugs for asthma. Semin Respir Crit Care Med 2012;33:685-94.
75. Michel S, Busato F, Genuneit J, et al.; PASTURE study group. Farm exposure and time trends in early childhood may influence DNA methylation in genes related to asthma and allergy. Allergy 2013;68:355-64.